Funding for this research was provided by:
Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (22390284)
Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (22-40134)
Received: 8 September 2020
Accepted: 14 January 2021
First Online: 4 February 2021
Ethics approval and consent to participate
: Animal experiments using MSCs were conducted in accordance with the protocol approved by the Institutional Animal Care and Use Committee of Nippon Medical School (27-199) and National Center of Neurology and Psychiatry (NCNP) Animal Ethics Committees (2012011, 2015004, and 19–30-06).
: Not applicable.
: Y. N-K., H. H-K., and T. O. were members of the Division of Cell and Gene Therapy, Nippon Medical School, which is an endowment department, supported with an unrestricted grant from JCR Pharmaceuticals Co., Ltd. and Kaneka Corporation. hDPSCs were provided by JCR Pharmaceuticals Co., Ltd. There is no COI related to other authors.